NOVOGEN LIMITED (ASX:NRT)
Industry: Pharmaceuticals, Biotechnology and Life Sciences
Activity: Pharmaceutical research and development and manufacturing and marketing of health supplements.
140 Wicks Road NORTH RYDE NSW 2113
Ph: (02) 9878 0088    Fax: (02) 9878 0055

Executives & Directors

Non Exec. Director
Non Exec. Director
Non Exec. Director
Non Exec. Director
Secretary
Please contact the ASX to change these details

Company Podcasts

Annual General Meeting
Mon, 31 Oct 2011
EGM
Fri, 6 May 2011
Interim Results
Mon, 28 Feb 2011
Annual General Meeting
Wed, 3 Nov 2010
Annual General Meeting
Fri, 30 Oct 2009 3:30pm
Full Year Results
Thu, 27 Aug 2009
Interim Results
Fri, 27 Feb 2009
Annual General Meeting
Fri, 31 Oct 2008 2:30pm
Annual General Meeting
Fri, 26 Oct 2007 2:30pm
Full Year Results
Fri, 24 Aug 2007
Novogen regains compliance with Nasdaq listing rules Tue, 24 Jan 2012
Marshall Edwards issued new patent for method of use Wed, 4 Jan 2012
Novogen modifies ADR program and invests in MEI Fri, 30 Dec 2011
Marshall Edwards granted new patent Wed, 21 Dec 2011
Marshall Edwards annual meeting of stockholders Wed, 23 Nov 2011
MEI to present at Lazard Cap Mkts Healthcare conference Fri, 11 Nov 2011
Refiled Appendix 4E Fri, 11 Nov 2011
Novogen announcement Fri, 11 Nov 2011
AGM 2011 - Chairman`s Address Mon, 31 Oct 2011
Novogen AGM results of neeting Mon, 31 Oct 2011

Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.